DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans…

Overview of attention for article published in BMC Cancer, May 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,801 followers.

Pubmed: DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone… http://t.co/a5pxUbBEpG

DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered a... http://t.co/eofBB32UtD #cancer

◈ DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alo... http://t.co/77TRBLrZEw ◈

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.